Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
25.52
+0.49 (1.96%)
Oct 19, 2026, 11:52 AM EDT - Market open
Zymeworks Market Cap
Zymeworks has a market cap or net worth of $1.81 billion as of October 19, 2026. It is the 7,156th most valuable company in the world and the 1,835th biggest in the United States. Its market cap has increased by 30.93% in one year.
Market Cap
1.81B
Enterprise Value
1.50B
1-Year Change
30.93%
Global Rank
Country Rank
#1,835 United States
Category
ChartMarket Cap Chart
Since April 28, 2017, Zymeworks's market cap has increased from $329.40M to $1.81B, an increase of 449.75%. That is a compound annual growth rate of 19.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 1.81B | -8.10% |
| Dec 31, 2025 | 1.97B | 95.40% |
| Dec 31, 2024 | 1.01B | 38.65% |
| Dec 29, 2023 | 727.30M | 46.87% |
| Dec 30, 2022 | 495.20M | -35.10% |
| Dec 31, 2021 | 763.00M | -64.77% |
| Dec 31, 2020 | 2.17B | 20.97% |
| Dec 31, 2019 | 1.79B | 281.53% |
| Dec 31, 2018 | 469.30M | 143.92% |
| Dec 29, 2017 | 192.40M | -41.59% |
| Apr 28, 2017 | 329.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Agios Pharmaceuticals | 1.87B |
| Novavax | 1.86B |
| Sarepta Therapeutics | 1.81B |
| Mineralys Therapeutics | 1.79B |
| Maravai LifeSciences Holdings | 1.76B |
| Palvella Therapeutics | 1.73B |
| Mesoblast | 1.70B |
| Xencor | 1.70B |